OR WAIT null SECS
- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
QxP Recognizes MHRA for its Support in Development of First VR Platform for Sterile Manufacturing
The UK’s MHRA has been recognized for its support of the development of an on-demand educational platform leveraging the power of virtual reality (VR), Virtuosi, from Quality Executive Partners (QxP).
The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has been recognized for its support of the development of an on-demand educational platform leveraging the power of virtual reality (VR), Virtuosi, from Quality Executive Partners (QxP).
In a Jan. 7, 2020 press release, QxP revealed that a team of five senior sterile experts from MHRA’s GMP Inspectorate participated in the pilot program as a primary beta partner. These experts reviewed select educational lecture content and VR experiences that have been created to simulate daily operations within controlled manufacturing and microbiology laboratory settings.
“We are so pleased to have the benefit of MHRA’s review and perspectives within our Virtuosi Sterile Manufacturing and Microbiology series,” said Crystal Mersh, CEO of QxP, in the press release. “The MHRA team has been a key regulatory supporter during our journey in developing this commercial VR educational technology. In fact, MHRA received our first deployed VR workstation, which in January 2020 is being upgraded to the full commercial release, providing an innovative source of internal training for the MHRA GMP Inspectorate.”
Source: Virtuosi
